Moderna (MRNA) Reports Q3 Loss, Tops Revenue Estimates

Moderna came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.43.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.